SAM
ABBV icon

Sabadell Asset Management’s AbbVie ABBV Stock Holding History

Sabadell Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,244
Closed -$1.24M – 112
2022
Q2 		$1.24M Hold
8,244
– – 0.26% 79
2022
Q1 		$1.43M Buy
8,244
+873
+12% +$127K 0.25% 86
2021
Q4 		$984K Buy
7,371
+723
+11% +$85.4K 0.16% 114
2021
Q3 		$717K Sell
6,648
-33,295
-83% -$3.8M 0.12% 129
2021
Q2 		$4.5M Buy
+39,943
New +$4.5M 0.78% 39

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sabadell Asset Management's ABBV Position: Q3 2022 in Review

Sabadell Asset Management sold out of AbbVie (ABBV) in Q3 2022, closing a stake of 8,244 shares — an estimated $1.24M sold.

Sabadell Asset Management first reported a position in ABBV in Q2 2021 and held it in 5 quarters. The position peaked at $4.5M in Q2 2021. 2,969 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

  • Sabadell Asset Management reported no remaining AbbVie position as of Q3 2022 after selling out during the quarter.
  • Sabadell Asset Management sold 8,244 AbbVie shares in Q3 2022, an estimated $1.24M.
  • Sabadell Asset Management first reported a position in AbbVie in Q2 2021 and held it in 5 quarters.
  • Sabadell Asset Management's AbbVie position peaked at $4.5M in Q2 2021.
  • 2,969 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on Sabadell Asset Management's 13F filing for Q3 2022, filed 23 Jan 2024.